Protocol for Women at Increased Risk of Developing Breast Cancer
Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
To assess the effects of twelve months of celecoxib administration by evaluating breast
tissue needle aspirations, to determine if cell growth can be slowed.